Cognitive & NootropicWell-Tolerated

Selank

Also known as: Selanc, TP-7, Tuftsin Analog

A synthetic anxiolytic peptide developed in Russia that provides anti-anxiety effects without sedation while also offering cognitive enhancement and immune modulation.

Half-Life

Short (minutes)

Typical Dose

200-400 mcg

Frequency

1-3x daily

Routes

Intranasal

Overview

Selank is a synthetic heptapeptide developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is based on Tuftsin, a naturally occurring tetrapeptide that is part of the IgG antibody molecule and has immunomodulatory properties.

The Selank molecule combines Tuftsin (Thr-Lys-Pro-Arg) with a stabilizing Pro-Gly-Pro sequence, creating a peptide with both anxiolytic and nootropic properties.

In Russia, Selank is an approved medication for:

  • Generalized anxiety disorder
  • Neurasthenia
  • Cognitive support

Key Characteristics

  • Origin: Synthetic analog of endogenous Tuftsin
  • Classification: Anxiolytic/nootropic peptide
  • Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro
  • Approved Status: Prescription medication in Russia
  • Unique Feature: Anxiolytic WITHOUT sedation or addiction potential

How Selank Differs from Benzodiazepines

| Feature | Selank | Benzodiazepines | |---------|--------|-----------------| | Sedation | None | Significant | | Addiction Potential | None | High | | Cognitive Effects | Enhancing | Impairing | | GABA Mechanism | Modulates, doesn't force | Direct agonist | | Withdrawal | None | Severe possible | | Daily Function | Preserved | Often impaired |

Mechanism

Selank operates through multiple distinct pathways, making it unique among anxiolytic agents.

Primary Mechanisms

1. GABA System Modulation

Unlike benzodiazepines, Selank modulates GABA gently:

  • Affects GABA-A receptor expression
  • Doesn't directly agonize receptors
  • Restores GABA homeostasis
  • Reduces anxiety without sedation
  • No tolerance or dependence development

2. Serotonin and Dopamine Balance

Neurotransmitter modulation:

  • Influences serotonin metabolism
  • Modulates dopaminergic transmission
  • Affects enkephalin processing
  • Creates mood stabilization
  • Without "high" or euphoria

3. BDNF Enhancement

Neurotrophic support:

  • Increases Brain-Derived Neurotrophic Factor
  • Supports neuroplasticity
  • Enhances learning and memory
  • Complements anxiolytic effects
  • Long-term brain health support

4. Immune Modulation (Tuftsin Heritage)

From its Tuftsin origins:

  • Enhances phagocyte activity
  • Modulates immune response
  • Potential antiviral properties
  • Supports stress-related immunity
  • Unique among anxiolytics

5. Inflammatory Cytokine Reduction

Anti-inflammatory in CNS:

  • Reduces IL-6 expression
  • Modulates inflammatory response
  • May benefit neuroinflammatory conditions
  • Supports overall brain health

Research

Research Note: Selank has extensive Russian clinical research and decades of medical use. Western research is limited but growing.

Anxiety Disorders (Approved Indication)

Russian Clinical Trials

Extensive clinical data shows:

  • Significant reduction in anxiety scores
  • Comparable efficacy to benzodiazepines
  • No sedation or cognitive impairment
  • No dependence development
  • Sustained effects with regular use

Generalized Anxiety Disorder (GAD)

  • Reduced Hamilton Anxiety scores
  • Improved quality of life
  • Better than placebo in controlled trials
  • Effects build over days of use

Cognitive Enhancement

Memory and Learning

Research demonstrates:

  • Enhanced memory consolidation
  • Improved attention span
  • Better cognitive flexibility
  • Particularly under stress conditions
  • Synergistic with reduced anxiety

Stress-Related Cognitive Decline

When stress impairs cognition:

  • Selank preserves cognitive function
  • Blocks stress-induced memory impairment
  • Maintains performance under pressure
  • Valuable for high-stress professions

Immune Function

Tuftsin-Derived Benefits

Unique immune properties:

  • Enhanced natural killer cell activity
  • Improved phagocyte function
  • Potential antiviral effects
  • May support recovery from illness
  • Stress-immune axis modulation

2025 Research Updates

Recent studies explore:

  • Immune support during chronic stress
  • Potential adjunct for infections
  • Stress-induced immunosuppression reversal

Depression (Adjunct Use)

While not primary indication:

  • May help anxiety-related depression
  • Enhances effects of antidepressants
  • Improves stress resilience
  • Being studied for combination therapy

Dosing

Disclaimer: Selank is not FDA-approved in the United States. It is approved in Russia for medical use. All dosing information is for research reference only.

Research Protocols

ProtocolDoseFrequencyDuration
Anxiolytic200-400 mcg2-3x daily14-21 days
Cognitive Support200-300 mcg1-2x daily14-21 days
N-Acetyl Selank100-200 mcg1-2x daily14-21 days
Acute Anxiety400 mcgAs neededSingle use

Forms Available

Standard Selank

  • Original formulation
  • Well-studied
  • Moderate duration

N-Acetyl Selank (NASA)

  • Acetylated version
  • Enhanced stability
  • Potentially more potent
  • May have longer duration

N-Acetyl Selank Amidate

  • Further modified
  • Claimed enhanced penetration
  • Used at lower doses
  • Limited research comparison

Administration Notes

Intranasal (Standard)

  • Most common route
  • Excellent absorption
  • Rapid onset (15-20 minutes)
  • Spray or drops into nostril
  • Alternate nostrils

Subcutaneous

  • Alternative route
  • More consistent absorption
  • Some prefer for precise dosing
  • Slightly slower onset

Timing

  • Can be used throughout day
  • Some prefer morning for all-day effect
  • Can redose for acute anxiety
  • Avoid very late evening (mild stimulation possible)

Cycling

While less necessary than with stimulants:

  • Consider 2-3 weeks on, 1 week off
  • Maintains optimal response
  • Prevents any potential tolerance
  • Russian protocols often continuous

Storage

  • Refrigerate for long-term storage
  • Room temperature okay for short periods
  • Protect from light
  • Nasal sprays: use within 2-4 weeks once opened

Pharmacokinetics

Absorption

  • Intranasal: Rapid, within minutes
  • Peak effects: 15-30 minutes
  • Good CNS penetration

Distribution

  • Crosses into brain
  • Wide tissue distribution
  • Concentrates at target sites

Metabolism

  • Rapid enzymatic breakdown
  • Pro-Gly-Pro provides some stability
  • Metabolites may be active

Elimination

  • Short half-life (minutes)
  • Multiple daily dosing preferred
  • No accumulation

Synergy & Stacking

Selank + Semax

The classic Russian nootropic combination:

  • Selank: Anxiety reduction, calm focus
  • Semax: Cognitive enhancement, BDNF
  • Complementary mechanisms
  • Can be used same day
  • Stagger doses by 30+ minutes

Selank + Adaptogens

Stress management stack:

  • Selank: Acute anxiolytic
  • Rhodiola/Ashwagandha: Long-term adaptation
  • Comprehensive stress support

Selank + Phenibut

Use with extreme caution:

  • Both affect GABA system
  • May enhance sedation
  • Phenibut has addiction potential
  • Generally not recommended

Safety

Known Side Effects

Common (mild)

  • Nasal irritation (intranasal)
  • Fatigue (rare, usually opposite)
  • Headache (uncommon)

Very Rare

  • Allergic reactions
  • Nasal congestion with chronic use

Contraindications

Use with caution if:

  • Pregnancy or breastfeeding
  • Active infections (theoretical immune concern)
  • Autoimmune conditions

Generally safe for:

  • Most healthy adults
  • Those seeking non-sedating anxiolytic
  • Cognitive enhancement seekers

Safety Advantage: Unlike benzodiazepines, Selank has no addiction potential, no withdrawal syndrome, and no cognitive impairment. It's remarkably well-tolerated.

Drug Interactions

  • Limited documented interactions
  • May enhance effects of other anxiolytics
  • Caution with immunosuppressants (immune modulation)
  • Generally safe with most medications

Monitoring

Subjective Assessment

  • Anxiety level tracking
  • Cognitive performance
  • Sleep quality (should improve or maintain)
  • Mood monitoring

No Required Labs

  • No specific blood tests required
  • Consider immune markers if using for immune support
  • General wellness labs as needed

Regulatory

Current Status

| Region | Status | |--------|--------| | Russia | Approved prescription medication | | United States | Not FDA-approved; research chemical | | European Union | Not approved; research use | | WADA | Not prohibited |

Legal Considerations

  • Legal in most jurisdictions
  • Not controlled substance
  • Available from peptide suppliers
  • Prescription only in Russia/CIS

Clinical Outlook

Selank represents an innovative approach to anxiety:

  • Non-addictive anxiolytic is highly desirable
  • Western interest growing
  • Potential for formal clinical trials
  • May influence future anxiolytic development
  • Unique immune-anxiety connection

References

[1] Seredenin SB, et al.. Pharmacological analysis of the anxiolytic action of Selank. Bulletin of Experimental Biology and Medicine (1995)
[2] Zozulya AA, et al.. Selank (TP-7) alters immune and behavioural parameters under psychoemotional stress. Russian Journal of Immunology (2001)
[3] Kozlovskii II, et al.. Selank and short peptides of the tuftsin family in the regulation of adaptive behavior in stress. Neuroscience and Behavioral Physiology (2003)
[4] Anxiolytic Peptide Research. Selank: Non-Benzodiazepine Approaches to Anxiety. CNS Drug Reviews (2025)